Xin Wang

ORCID

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Venues

Journal of diabetes

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Ziling Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study. Journal of diabetes 14 (12) (2022)
Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Ziling Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study. Journal of diabetes 14 (12) (2022)
Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Ziling Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study. Journal of diabetes 14 (12) (2022)
Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Ziling Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study. Journal of diabetes 14 (12) (2022)
Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Ziling Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II study. Journal of diabetes (2022)

Xin Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xin Wang